Inez Denham
Biographic Data
| ID | 10016760 |
|---|---|
| NAME | Inez Denham |
| GIVEN NAMES | Inez |
| FAMILY NAME | Denham |
| SIGNATURE | DENHAM I |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Stakeholder perspectives on scaling up potassium-enriched salt to reduce cardiovascular disease in Australia
Improving stakeholder understanding of the benefit of switching to potassium-enriched salt in Australia may require a coordinated advocacy strategy that disseminates the evidence and addresses misconceptions. Efforts to drive increased supply and demand could be advanced using a multi-sectoral approach that focuses on supporting industry uptake, encouraging consumer demand, and informing policy implementation
Levodopa-based device-aided therapies for the treatment of advanced Parkinson’s disease
Introduction: Parkinson's disease (PD) is an incurable, progressive, neurodegenerative disorder. As PD advances and symptoms progress, patients become increasingly dependent on family and carers. Traditional cost-effectiveness analyses (CEA) only consider patient and payer-related outcomes, failing to acknowledge impacts on families, carers, and broader society. This novel Social Return on Investment (SROI) analysis aimed to evaluate the broader …
No prominent works on this page.
Levodopa-based device-aided therapies for the treatment of advanced Parkinson’s disease
Introduction: Parkinson's disease (PD) is an incurable, progressive, neurodegenerative disorder. As PD advances and symptoms progress, patients become increasingly dependent on family and carers. Traditional cost-effectiveness analyses (CEA) only consider patient and payer-related outcomes, failing to acknowledge impacts on families, carers, and broader society. This novel Social Return on Investment (SROI) analysis aimed to evaluate the broader …
Stakeholder perspectives on scaling up potassium-enriched salt to reduce cardiovascular disease in Australia
Improving stakeholder understanding of the benefit of switching to potassium-enriched salt in Australia may require a coordinated advocacy strategy that disseminates the evidence and addresses misconceptions. Efforts to drive increased supply and demand could be advanced using a multi-sectoral approach that focuses on supporting industry uptake, encouraging consumer demand, and informing policy implementation
Economics (2 works) · Medicine (2 works) · Political science (2 works) · Business (1 work) · Consumer Attitudes and Food Labeling (1 work) · Context (archaeology (1 work) · Disease (1 work) · Environmental health (1 work) · Government (linguistics (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work)